Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Income from Continuing Operations (2016 - 2025)

Pediatrix Medical (MD) has disclosed Income from Continuing Operations for 17 consecutive years, with 45595000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations rose 61.03% to 45595000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 177300000.0, a 275.14% increase, with the full-year FY2025 number at 216432000.0, up 313.79% from a year prior.
  • Income from Continuing Operations was 45595000.0 for Q4 2025 at Pediatrix Medical, down from 71708000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 71708000.0 in Q3 2025 to a low of 153025000.0 in Q2 2024.
  • A 5-year average of 9785750.0 and a median of 26141000.0 in 2022 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: surged 1300.6% in 2021, then crashed 641.07% in 2024.
  • Pediatrix Medical's Income from Continuing Operations stood at 40276000.0 in 2021, then crashed by 40.41% to 24000000.0 in 2022, then crashed by 578.25% to 114780000.0 in 2023, then skyrocketed by 124.67% to 28314000.0 in 2024, then surged by 61.03% to 45595000.0 in 2025.
  • Per Business Quant, the three most recent readings for MD's Income from Continuing Operations are 45595000.0 (Q4 2025), 71708000.0 (Q3 2025), and 39260000.0 (Q2 2025).